Jade Biosciences JBIO Cash Flow Statement (2020-2026)

NASDAQ JBIO
$19.91 +0.06 (+0.28%)
As of: Sep 4, 2026 · 2:23 PM EDT
Reported Financials

Jade Biosciences Quarterly Cash Flow Statement

Periods 25 quarters
Latest Jun 2026

Jade Biosciences reported cash from operations of -$43.64M and free cash flow of -$43.64M for the quarter ended Jun 2026, down 116.5% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-6.18M-8.22M-10.91M-11.99M-13.59M-14.92M-16.52M-19.02M-19.56M-20.36M-23.19M-24.77M-14.58M-37.11M-38.17M-32.13M-25.15M-31.89M-40.45M-55.77M
Share-based Compensation
2.80M0.85M3,703.93M3,953.39M4.15M1.73M5.11M5.16M5.24M3.25M6.46M5.63M3.71M1.26M2.42M9.35M9.70M9.40M7.41M13.61M
Cash from Operations
-6.53M-13.09M-5.66M-8.88M-9.72M-14.87M-11.42M-14.94M-15.61M-14.80M-23.67M-6.80M-22.61M-18.76M-20.16M-22.12M-33.66M-24.10M-43.64M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.03M-0.06M-0.29M-0.59M-0.67M-0.64M-0.81M-0.94M-0.76M-0.69M-0.46M-0.34M-0.23M0.61M0.49M0.36M
Change in Working Capital
Change in Account Payables
1.09M-1.04M1.59M-0.71M2.24M-1.75M2.12M0.77M-2.01M-1.04M0.83M0.95M0.30M1.29M2.68M2.26M-4.88M0.30M2.33M2.10M
Change in Accured Expenses
-0.03M0.03M0.50M-0.31M1.44M2.04M0.72M1.84M3.39M4.05M-3.06M0.59M0.24M3.98M-1.95M4.81M4.58M-3.50M5.77M0.08M
Other Working Capital Changes
2.06M4.73M-2.13M-3.36M1.12M-0.30M-0.64M0.73M0.03M-0.61M2.11M2.65M0.21M0.27M0.51M0.85M0.41M10.20M-5.44M2.83M
Investing Activities
Capital Expenditures
0.20M0.02M0.09M0.34M-0.02M1.47M0.09M-0.03M0.02M0.06M-0.00M-2.51M1.72M0.23M-0.06M0.20M0.06M0.00M
Change in Acquisitions & Divestments
12.52M47.23M30.25M64.75M31.00M36.75M34.75M33.50M23.58M18.00M21.00M13.13M12.85M65.43M44.69M
Cash from Investing Activities
-0.06M-113.34M-20.40M8.19M4.64M14.49M15.38M3.98M-13.13M5.65M8.83M13.13M12.85M-12.99M-148.71M-98.16M-8.47M-97.63M
Financing Activities
Other financing activities
0.17M0.44M0.22M0.33M0.10M0.34M0.70M0.51M0.02M0.25M-1.34M0.04M1.53M
Debt Issuance and Repayment
Long-Term Debt Issuances
95.00M95.00M
Change in Capital Stock
Net Shares Issued and Repurchased
3.23M0.25M0.95M1.16M1.55M1.40M3.90M0.10M7.91M2.96M
Net Equity Issued and Repurchased
63.68M-0.25M0.31M
Misc.
Cash from Financing Activities
128.31M-0.25M0.04M0.36M0.22M45.29M0.02M0.46M0.47M94.77M92.00M-0.70M191.31M170.16M-0.80M193.52M
Exchange Rate Effect
-0.02M-0.01M-0.07M
Change in Cash
121.73M-126.68M-26.06M-0.68M-5.04M-0.02M4.17M34.33M-28.72M-8.69M-14.37M87.97M69.39M-19.46M171.01M-170.84M38.33M-33.35M52.16M
Free Cash Flow
-6.73M-13.12M-5.75M-9.22M-9.70M-16.33M-11.51M-14.91M-15.63M-14.86M-23.67M2.51M-8.52M-22.84M-18.70M-20.36M-22.18M-33.66M-24.10M-43.64M
Net Cash Flow
121.73M-126.68M-26.06M-0.68M-5.04M-0.02M4.17M34.33M-28.72M-8.69M-14.37M87.97M82.52M-6.61M158.16M-170.83M38.34M-33.37M52.25M